Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cabergoline Versus Calcium Gluconate Infusion in the Prevention of Ovarian Hyperstimulation Syndrome. A Randomized Controlled Trial

NCT02875587 is registered in ClinicalTrials.gov with Aljazeera Hospital as lead sponsor.

NCT NCT02875587
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02875587 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cabergoline Versus Calcium Gluconate Infusion in the Prevention of Ovarian Hyperstimulation Syndrome. A Randomized Controlled Trial
Lead sponsor
Aljazeera Hospital
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2016
Completion date
December 31, 2018
Enrollment
170 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

ohss